Helicobacter pylori: Past, Present, and Future

References

• Marshall B J, Warren R J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–5
   PubMed Web of Science ®Google Scholar
• Blaser M J. Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987; 93: 371–83
   PubMed Web of Science ®Google Scholar
• Price A, Levi, Dolby J M, et al. Campylobacterpyloridis in peptic ulcer disease: microbiology, pathology and scanning electron microscopy. Gut 1985; 26: 1183–8
   PubMed Web of Science ®Google Scholar
• Ramirez-Ramoz A, Gilman G, Spira W, et al. Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. Gut 1992; 33: 604–5
   PubMedGoogle Scholar
• Li Y Y, Hu P J, Du G G, Hazell S L. The prevalence of Helicobacter pylori infection in the Peoples Republic of China. Am J Gastroenterol 1991; 86: 446–9
   PubMed Web of Science ®Google Scholar
• Britt D P, Barakat M H, Tungekar M F, et al. Helicobacter pylori in dyspeptic patients in Kuwait. J Clin Pathol 1990; 43: 987–91
   PubMedGoogle Scholar
• Kazi J I, Jafarey N A, Alam S M, et al. Association of Helicobacter pylori with acid peptic disease in Karachi. JPMA 1990; 40: 240–1
   Google Scholar
• Price A B. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209–22
   PubMed Web of Science ®Google Scholar
• Evans D JJ, Evans D G, Kirkpatrick S S, Graham D Y. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathol 1991; 10: 15–26
   PubMed Web of Science ®Google Scholar
• Turbett G R, Nandapalan N, Campbell I G, Nikoletti S M, Mee B J. Characterisation of the urease from Helicobacter pylori and comparison with the ureases from related spiral gastric bacteria. FEMS Microbiol Immunol 1991; 3: 19–24
   PubMedGoogle Scholar
• Hawtin P R, Stacey A R, Newell D G. Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies. J Gen Microbiol 1990; 136: 1995–2000
   PubMedGoogle Scholar
• Thillainayagam A V, Arvind A S, Cook R S, Harrison I G, Tabaqchali S, Farthing M J. Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut 1991; 32: 467–9
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Shallcross T M, Heatley R V, Wyatt J I. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991; 44: 326–8
   PubMed Web of Science ®Google Scholar
• Newell D G, Hawtin P R, Stacey A R, MacDougall M H, Ruddle A C. Estimation of prevalence of Helicobacter pylori infection in an asymptomatic elderly population comparing urea breath test and serology. J Clin Pathol 1991; 44: 385–7
   PubMedGoogle Scholar
• Kosunen T U, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893–5
   PubMed Web of Science ®Google Scholar
• Sobala G M, Crabtree J E, Pentith J A, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94–6
   PubMed Web of Science ®Google Scholar
• Collins J SA, Bamford K B, Sloan J M, et al. Screening for H. pylori antibody could improve selectivity for endoscopy in young patients. Gastroenterology 1992; 102(Pt 2)A52
   Google Scholar
• Debongnie J C, Pauwels S, Raat A, de Meeus Y, Haot J, Mainguet P. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14-urea breath test. J Nucl Med 1991; 32: 1192–8
   PubMed Web of Science ®Google Scholar
• Graham D Y, Malaty H M, Evans D G, Evans D J, Klein P D, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495–501
   PubMed Web of Science ®Google Scholar
• Coelho L G, Chausson Y, Passos M C, et al. 14C-urea breath test to diagnose gastric helicobacter pylori colonization. Gastroenterol Clin Biol 1990; 14: 801–5
   PubMedGoogle Scholar
• Henze E, Malfertheiner P, Clausen M, Burkhardt H, Adam W E. Validation of a simplified carbon-14-urea breath test for routine use for detecting Helicobacter pylori noninvasively. J Nucl Med 1990; 31: 1940–4
   PubMed Web of Science ®Google Scholar
• Dill S, Payne James J J, Misiewicz J J, et al. Evaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia. Gut 1990; 31: 1237–41
   PubMed Web of Science ®Google Scholar
• Logan R PH, Dill S, Bauer F E, et al. The European 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 905–11
   Google Scholar
• Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302–5
   PubMed Web of Science ®Google Scholar
• Burstein M, Monge E, Leon Baura R, et al. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13: 154–6
   PubMed Web of Science ®Google Scholar
• Hansson L-E, Engstrand L, Evans D J, et al. Helicobacter pylori seropostitivity is a risk factor for gastric adenocarcinoma (G AC). Gastroenterology 1992; 102(Pt 2)A361
   Google Scholar
• Parsonnet J, Vandersteen D, Goates J., Sibley R K, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640–3
   PubMedGoogle Scholar
• Nomura K, Stemmermann G N, Chyou P H, Kato I, Perez-Perez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1123–36
   PubMedGoogle Scholar
• Parsonnet J, Friedmann D F, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
   PubMed Web of Science ®Google Scholar
• Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569–74
   PubMed Web of Science ®Google Scholar
• Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608–11
   PubMed Web of Science ®Google Scholar
• Barker D JP, Coggon D, Osmond C, Wickham C. Poor housing in childhood and high rates of stomach cancer in England and Wales. Br J Cancer 1990; 61: 575–8
   PubMed Web of Science ®Google Scholar
• Mendall M A, Coggin P M, Molineaux Nicola, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896–7
   PubMed Web of Science ®Google Scholar
• Sitas F, Forman D, Yarnell J W, et al. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 1991; 32: 25–8
   PubMed Web of Science ®Google Scholar
• Coggon D, Osmond C, Barket D JP. Stomach cancer and migration within England and Wales. Br J Cancer 1990; 61: 573–4
   PubMedGoogle Scholar
• Coggon D, Osmond C, Barker D JP. Stomach cancer and migration within England and Wales. Br J Cancer 1990; 61: 573–4
   PubMedGoogle Scholar
• Graham D Y, Lew G M, Evans D G, Evans D JJ, Klein P D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991; 115: 266–9
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Klein P D, et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 705–8
   PubMed Web of Science ®Google Scholar
• Coelho L GV, Passos M CF, Chausson Y, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. Scand J Gastroenterol 1992; 27: 362–6
   PubMed Web of Science ®Google Scholar
• Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastro Hepatol 1991; 6: 131–7
   PubMed Web of Science ®Google Scholar
• Logan R P, Poison R J, Baron J H, Misiewicz J J. Follow-up after anti-Helicobacter pylori treatment. Lancet 1991; 337: 562–3
   PubMedGoogle Scholar
• Mannes G A, Bayerdorffer E, Hochter W, et al. Decreased relapse rate after antibacterial treatment of Helicobacter pylori associated duodenal ulcers. Gastroenterology 1992; 102(Pt 2)A 118
   Google Scholar
• Marshall B J, Goodwin C S, Warren J R, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
   PubMed Web of Science ®Google Scholar
• Endo S, Ohkusa T, Okayasu I, et al. Detection of Helicobacter pylori in early gastric cancer: comparison between intestinal and diffuse type gastric adenocarcinomas. Gastroenterology 1992; 102(Pt 2)A64
   Google Scholar
• Smith J TL, Pounder R E, Nwokolo C U, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects with Campylobacter pylori. Gut 1990; 31: 522–5
   PubMed Web of Science ®Google Scholar
• McColl K E, FuUarton G M, Chittajalu R, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339–46
   PubMed Web of Science ®Google Scholar
• Graham D Y., Opekun A, Lew G M, Klein P D, Walsh J H. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991; 100: 1571–5
   PubMed Web of Science ®Google Scholar
• Chittajallu R S, Neithercut W D, MacDonald A M, McColl K E. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut 1991; 32: 21–4
   PubMed Web of Science ®Google Scholar
• Moss M, Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut 1992; 33: 289–92
   PubMed Web of Science ®Google Scholar
• Prewett E J, Smith J TL, Nwokolo C U, Hudson M, Sawyer A M, Pounder R E. Eradication of Helicobacter pylori abolished 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991; 5: 283–96
   PubMed Web of Science ®Google Scholar
• Levi S, Beardhall K, Swift I, Foulkes A, Playford R, Calam J. Antral Helicobacter pylori hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. Br Med J 1989; 299: 1504–5
   PubMed Web of Science ®Google Scholar
• Levi S, Haddad G, Ghosh P, Beardshall K, Playford R, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167–8
   PubMed Web of Science ®Google Scholar
• Murthy U K, Linscheer R, Cho C. The hypergastrinemia in Helicobacter pylori gastritis is due to a decrease in antral D cell density and D:G cell ratio. Gastroenterology 1992; 102(Pt 2)A130
   Google Scholar
• Haruma K, Sumii K, Okamoto S, et al. Helicobacter pylori infection causes low antral somatostatin content: pathogenesis of inappropriate hypergastrinemia. Gastroenterology 1992; 102(Pt 2)A80
   Google Scholar
• Chittajallu R S, Dorrian C A, Ardrill J ES, McColl K EL. Effect of Helicobacterpylroi on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992; 27: 20–4
   PubMed Web of Science ®Google Scholar
• Fraser A G, Prewett E J, Pounder R E, Samloff I M. Twenty-four hour hyperpepsinogenaemia in Helicobacter pylori positive subjects is abolished by eradication of infection. Aliment Pharmacol Ther 1992; 6: 389–94
   PubMed Web of Science ®Google Scholar
• Mertz H, Sytnik B, Samloff I M, Walsh J H. Pepsinogen and pepsin in Helicobacter pylori infection. Gastroenterology 1992; 102(Pt 2)A 124
   Google Scholar
• Fraser A G, Prewett E J, Pounder R E, Samloff I M. Twentyfour hour hyperpepsinogenanaemia in Helicobacter pylori positive subjects is abolished by eradication of infection. Gastroenterology 1992; 102: A70, Part 2
   Google Scholar
• Crabtree J E, Taylor J D, Wyatt J R, et al. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332–5
   PubMed Web of Science ®Google Scholar
• Fraser A G, Bickley J, Owen R J, Pounder R E. Genomic het-erogeneityin Helicobacter pylori: achlorhydria at time of colonisation unlikely to be a factor. Gastroenterology 1992; 102(Pt 2)A70
   Google Scholar
• Logan R PH, Gummett P A, Misiewicz J J, Karim O N, Walker N M, Baron J H. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 1249–52
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Malaty H M, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–6
   PubMed Web of Science ®Google Scholar
• Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Anti-microb Agents Chemother 1991; 35: 490–6
   PubMed Web of Science ®Google Scholar
• Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337: 1486
   PubMed Web of Science ®Google Scholar
• McCarthy C J, Collins R, Beattie C, et al. Long term study of omeprazole triple therapy in Helicobacter pylori associated duodenal ulcer. Gastroenterology 1992; 102(Pt 2)A123
   Google Scholar
• Lamouliatte H, Bernard P H, Cayla R, et al. Controlled study of omperazole amoxycillin tinidazole vs ranitidine amoxycillin tinidazole in Helicobacter pylori associated duodenal ulcers (DU). Final and long term results. Gastroenterology 1992; 102(Pt 2)A106
   Google Scholar
• Bayerdorffer E, Mannes G A, Sommer A, et al. High dose Omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Gastroenterology 1992; 102(Pt 2)
   PubMedGoogle Scholar
• De Koster E, Nyst J F, Deprez C, et al. Hp treatment: disappointing results with amoxycillin plus omeprazole. Gastroenterology 1992; 102(Pt 2)
   Google Scholar
• Unge P, Eriksson K, Bergman B, et al. Omeprazole and amoxycillin in patients with duodenal ulcer: Helicobacter pylori eradication and remission of ulcers and symptoms during a 6 month follow-up. A double blind comparative study. Gastroenterology 1992; 102(Pt2)
   Google Scholar
• Seppala K, Pikkarainen P, Karvonen A L, et al. The role of Helicobacter pylori (Hp) eradication in gastric ulcer healing and relapse. Gastroenterology 1992; 102(Pt 2)A162
   Google Scholar
• Lanza F L, Evans D G, Graham D Y. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991; 86: 735–7
   PubMedGoogle Scholar
• Graham D Y, Lidsky M D, Cox A M, et al. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653–7
   PubMed Web of Science ®Google Scholar
• Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. Br Med J 1991; 303: 1238–40
   PubMed Web of Science ®Google Scholar
• Oddsson E, Gudjonsson H, Theodors A, et al. De-Nol or De-Nol plus metronidazole in the treatment of Helicobacter pylori positive patients with non ulcer dyspepsia: symptomatic response and eradication rate. Gastroenterology 1992; 102(Pt 2)A137
   Google Scholar